Symbols / NYXH Stock $2.92 -5.19% Nyxoah SA

Healthcare • Medical Instruments & Supplies • Belgium • NGM
NYXH (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. Olivier Taelman
Exch · Country NGM · Belgium
Market Cap 127.49M
Enterprise Value 136.32M
Income -83.64M
Sales 15.33M
FCF (ttm) -43.55M
Book/sh 1.34
Cash/sh 0.60
Employees 153
Insider 10d —
IPO Apr 28, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -1.92
PEG —
P/S 8.32
P/B 2.17
P/C —
EV/EBITDA -1.68
EV/Sales 8.89
Quick Ratio 0.86
Current Ratio 0.99
Debt/Eq 100.58
LT Debt/Eq —
EPS (ttm) -2.78
EPS next Y -1.52
EPS Growth —
Revenue Growth 4.99%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-08-05
Earnings (prior) 2026-03-19
ROA -44.59%
ROE -129.97%
ROIC —
Gross Margin 60.71%
Oper. Margin -3.22%
Profit Margin 0.00%
Shs Outstand 43.66M
Shs Float 24.24M
Insider Own 37.04%
Instit Own 22.10%
Short Float 1.03%
Short Ratio 9.02
Short Interest 326.19K
52W High 8.64
vs 52W High -66.20%
52W Low 2.76
vs 52W Low 5.80%
Beta —
Impl. Vol. —
Rel Volume 1.45
Avg Volume 49.03K
Volume 71.08K
Target (mean) $9.51
Tgt Median $9.99
Tgt Low $4.95
Tgt High $13.11
# Analysts 4
Recom Buy
Prev Close $3.08
Price $2.92
Change -5.19%
About

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat obstructive sleep apnea. Its lead solution is the Genio system, a hypoglossal neurostimulations therapy for obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$9.51
Mean price target
2. Current target
$2.92
Latest analyst target
3. DCF / Fair value
$-17.95
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.92
Low
$4.95
High
$13.11
Mean
$9.51

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-05-13 reit Piper Sandler Overweight → Overweight $7
2026-05-12 down Stifel Buy → Hold $5
2026-04-10 main Stifel Buy → Buy $8
2026-03-23 reit Cantor Fitzgerald Overweight → Overweight $11
2026-03-20 main Stifel Buy → Buy $10
2026-01-29 main Stifel Buy → Buy $11
2025-11-14 reit Piper Sandler Overweight → Overweight $9
2025-04-21 main Stifel Buy → Buy $14
2025-04-08 reit HC Wainwright & Co. Buy → Buy $15
2025-03-26 main HC Wainwright & Co. Buy → Buy $15
2025-03-14 main Stifel Buy → Buy $15
2024-12-13 reit HC Wainwright & Co. Buy → Buy $17
2024-11-05 reit Cantor Fitzgerald Overweight → Overweight $16
2024-10-11 main HC Wainwright & Co. Buy → Buy $17
2024-09-30 reit HC Wainwright & Co. Buy → Buy $18
2024-08-07 main Cantor Fitzgerald Overweight → Overweight $16
2024-08-07 reit HC Wainwright & Co. Buy → Buy $18
2024-08-07 main Oppenheimer Outperform → Outperform $13
2024-06-24 main Stifel Buy → Buy $19
2024-05-24 main HC Wainwright & Co. Buy → Buy $18
News
RSS: Latest NYXH news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
10.02
+121.63%
4.52
+3.98%
4.35
+40.99%
3.08
Operating Revenue
10.02
+121.63%
4.52
+3.98%
4.35
+40.99%
3.08
Cost Of Revenue
3.69
+138.02%
1.55
-6.28%
1.66
+44.00%
1.15
Reconciled Cost Of Revenue
0.53
+352.54%
0.12
-65.09%
0.34
+156.06%
0.13
Gross Profit
6.33
+113.07%
2.97
+10.29%
2.69
+39.19%
1.93
Operating Expense
89.27
+44.50%
61.78
+29.26%
47.79
+38.80%
34.43
Research And Development
42.82
+24.76%
34.33
+28.79%
26.65
+68.03%
15.86
Selling General And Administration
46.44
+70.87%
27.18
+31.64%
20.64
+15.07%
17.94
General And Administrative Expense
46.44
+70.87%
27.18
+31.64%
20.64
+15.07%
17.94
Salaries And Wages
26.34
+130.94%
11.41
+27.51%
8.95
+11.04%
8.06
Other Gand A
19.17
+31.13%
14.62
+40.61%
10.40
+30.94%
7.94
Other Operating Expenses
-1.32
-30.65%
-1.01
-85.29%
-0.54
-92.23%
-0.28
Total Expenses
92.96
+46.79%
63.33
+28.07%
49.45
+38.97%
35.58
Operating Income
-82.94
-41.04%
-58.81
-30.39%
-45.10
-38.78%
-32.50
Total Operating Income As Reported
-83.48
-41.96%
-58.81
-30.39%
-45.10
-38.78%
-32.50
EBITDA
-82.90
-56.93%
-52.83
-25.54%
-42.08
-50.89%
-27.89
Normalized EBITDA
-80.98
-48.30%
-54.61
-32.68%
-41.16
-33.75%
-30.77
Reconciled Depreciation
4.48
+64.97%
2.72
+15.17%
2.36
+22.15%
1.93
EBIT
-87.39
-57.32%
-55.55
-24.99%
-44.44
-49.03%
-29.82
Total Unusual Items
-1.92
-207.93%
1.78
+292.22%
-0.93
-132.07%
2.88
Total Unusual Items Excluding Goodwill
-1.92
-207.93%
1.78
+292.22%
-0.93
-132.07%
2.88
Special Income Charges
-0.55
0.00
0.00
—
Other Special Charges
-0.12
—
—
—
Write Off
0.50
0.00
0.00
—
Net Income
-90.08
-52.08%
-59.24
-37.08%
-43.21
-38.39%
-31.23
Pretax Income
-89.08
-57.85%
-56.43
-26.37%
-44.66
-48.58%
-30.06
Net Non Operating Interest Income Expense
-4.22
-804.17%
0.60
-56.28%
1.37
+410.66%
-0.44
Interest Expense Non Operating
1.69
+90.86%
0.89
+308.29%
0.22
-8.44%
0.24
Net Interest Income
-4.22
-804.17%
0.60
-56.28%
1.37
+410.66%
-0.44
Interest Expense
1.69
+90.86%
0.89
+308.29%
0.22
-8.44%
0.24
Interest Income Non Operating
1.83
-26.70%
2.50
-2.68%
2.57
+591.13%
0.37
Interest Income
1.83
-26.70%
2.50
-2.68%
2.57
+591.13%
0.37
Other Income Expense
-1.92
-207.93%
1.78
+292.22%
-0.93
-132.07%
2.88
Gain On Sale Of Security
-1.37
-177.22%
1.78
+292.22%
-0.93
-132.07%
2.88
Tax Provision
1.01
-64.02%
2.80
+294.05%
-1.45
-223.61%
1.17
Tax Rate For Calcs
0.00
+0.00%
0.00
+672.61%
0.00
-87.06%
0.00
Tax Effect Of Unusual Items
-0.48
-207.93%
0.44
+1585.09%
-0.03
-104.15%
0.72
Net Income Including Noncontrolling Interests
-90.08
-52.08%
-59.24
-37.08%
-43.21
-38.39%
-31.23
Net Income From Continuing Operation Net Minority Interest
-90.08
-52.08%
-59.24
-37.08%
-43.21
-38.39%
-31.23
Net Income From Continuing And Discontinued Operation
-90.08
-52.08%
-59.24
-37.08%
-43.21
-38.39%
-31.23
Net Income Continuous Operations
-90.08
-52.08%
-59.24
-37.08%
-43.21
-38.39%
-31.23
Normalized Income
-88.65
-46.35%
-60.57
-43.13%
-42.32
-26.74%
-33.39
Net Income Common Stockholders
-90.08
-52.08%
-59.24
-37.08%
-43.21
-38.39%
-31.23
Diluted EPS
-2.36
-30.68%
-1.81
-17.09%
-1.54
-27.79%
-1.21
Basic EPS
-2.36
-30.68%
-1.81
-17.09%
-1.54
-27.79%
-1.21
Basic Average Shares
38.11
+16.38%
32.75
+17.08%
27.97
+8.29%
25.83
Diluted Average Shares
38.11
+16.38%
32.75
+17.08%
27.97
+8.29%
25.83
Diluted NI Availto Com Stockholders
-90.08
-52.08%
-59.24
-37.08%
-43.21
-38.39%
-31.23
Depreciation Amortization Depletion Income Statement
1.32
+3.12%
1.28
+23.22%
1.04
+14.00%
0.91
Depreciation And Amortization In Income Statement
1.32
+3.12%
1.28
+23.22%
1.04
+14.00%
0.91
Gain On Sale Of PPE
-0.16
0.00
0.00
—
Insurance And Claims
0.43
-15.66%
0.51
-48.12%
0.98
-34.51%
1.50
Rent And Landing Fees
0.49
-22.85%
0.64
+101.58%
0.32
-27.95%
0.44
Rent Expense Supplemental
0.49
-22.85%
0.64
+101.58%
0.32
-27.95%
0.44
Total Other Finance Cost
4.36
+328.81%
1.02
+3.35%
0.98
+70.83%
0.58
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
118.47
-25.21%
158.41
+27.59%
124.16
-15.00%
146.07
Current Assets
61.21
-37.59%
98.08
+43.50%
68.35
-31.83%
100.26
Cash Cash Equivalents And Short Term Investments
48.00
-43.89%
85.56
+48.15%
57.75
-39.12%
94.86
Cash And Cash Equivalents
30.00
-12.24%
34.19
+58.20%
21.61
+20.81%
17.89
Cash Equivalents
22.13
-21.58%
28.22
+208.15%
9.16
+25338.89%
0.04
Cash Financial
7.87
+31.91%
5.97
-52.09%
12.45
-30.25%
17.85
Other Short Term Investments
18.00
-64.96%
51.37
+42.15%
36.14
-53.05%
76.97
Receivables
7.58
+23.02%
6.16
+9.47%
5.63
+73.83%
3.24
Accounts Receivable
5.25
+55.35%
3.38
+22.63%
2.76
+88.52%
1.46
Other Receivables
0.90
-15.98%
1.07
-11.64%
1.21
+57.68%
0.77
Taxes Receivable
1.43
-16.57%
1.71
+3.02%
1.66
+64.81%
1.01
Inventory
4.66
-1.19%
4.72
+42.26%
3.31
+275.85%
0.88
Raw Materials
1.31
+21.76%
1.08
-18.74%
1.33
+166.87%
0.50
Work In Process
1.85
-27.30%
2.55
+66.41%
1.53
+1430.00%
0.10
Finished Goods
1.49
+37.06%
1.09
+139.04%
0.46
+60.56%
0.28
Prepaid Assets
0.31
-58.17%
0.73
—
—
Current Deferred Assets
0.66
-27.78%
0.92
—
—
Hedging Assets Current
0.00
0.00
-100.00%
0.34
+34200.00%
0.00
Other Current Assets
—
1.66
+25.64%
1.32
+2.65%
1.28
Total Non Current Assets
57.26
-5.08%
60.32
+8.09%
55.81
+21.82%
45.81
Net PPE
5.34
-35.20%
8.25
+3.42%
7.98
+41.95%
5.62
Gross PPE
10.29
-26.20%
13.94
+15.77%
12.04
+43.58%
8.38
Accumulated Depreciation
-4.94
+13.15%
-5.69
-40.02%
-4.06
-46.89%
-2.77
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
1.70
-66.39%
5.06
+9.86%
4.60
+27.04%
3.62
Machinery Furniture Equipment
2.66
-7.87%
2.88
+12.40%
2.56
+22.79%
2.09
Construction In Progress
0.03
-98.67%
2.26
+9.93%
2.06
+186.21%
0.72
Other Properties
1.78
-6.20%
1.90
+26.72%
1.50
+20.08%
1.25
Leases
4.12
+124.18%
1.84
+39.73%
1.31
+86.65%
0.70
Goodwill And Other Intangible Assets
50.11
-0.54%
50.38
+8.10%
46.61
+16.60%
39.97
Other Intangible Assets
50.11
-0.54%
50.38
+8.10%
46.61
+16.60%
39.97
Non Current Accounts Receivable
1.63
+8.11%
1.50
+29.07%
1.17
+573.99%
0.17
Non Current Deferred Assets
0.09
+14.47%
0.08
+35.71%
0.06
+19.15%
0.05
Non Current Deferred Taxes Assets
0.09
+14.47%
0.08
+35.71%
0.06
+19.15%
0.05
Total Liabilities Net Minority Interest
69.34
+53.57%
45.15
+72.76%
26.14
+1.51%
25.75
Current Liabilities
48.96
+127.40%
21.53
+49.06%
14.44
-3.15%
14.91
Payables And Accrued Expenses
22.23
+25.71%
17.69
+45.61%
12.15
-7.87%
13.18
Payables
9.35
+15.96%
8.07
+32.45%
6.09
+7.64%
5.66
Accounts Payable
5.17
+37.85%
3.75
-8.61%
4.10
+119.01%
1.87
Other Payable
—
—
0.20
+52.67%
0.13
Current Accrued Expenses
12.88
+33.88%
9.62
+58.84%
6.06
-19.52%
7.53
Employee Benefits
—
0.00
-100.00%
0.01
0.00
Pensionand Other Post Retirement Benefit Plans Current
0.55
-38.87%
0.90
+14.16%
0.79
+29.25%
0.61
Total Tax Payable
4.18
-3.06%
4.32
+117.15%
1.99
-45.59%
3.65
Current Debt And Capital Lease Obligation
23.77
+1640.04%
1.37
+12.43%
1.22
+9.66%
1.11
Current Debt
22.99
+9170.16%
0.25
-31.87%
0.36
-6.43%
0.39
Other Current Borrowings
22.99
+9170.16%
0.25
-31.87%
0.36
-6.43%
0.39
Current Capital Lease Obligation
0.78
-30.32%
1.12
+31.37%
0.85
+18.36%
0.72
Current Deferred Liabilities
0.89
+664.10%
0.12
0.00
—
Current Deferred Revenue
0.89
+664.10%
0.12
0.00
—
Other Current Liabilities
1.51
+3.64%
1.46
+402.07%
0.29
+3122.22%
0.01
Total Non Current Liabilities Net Minority Interest
20.38
-13.71%
23.62
+102.04%
11.69
+7.92%
10.83
Long Term Debt And Capital Lease Obligation
16.71
-21.52%
21.29
+85.28%
11.49
+6.63%
10.78
Long Term Debt
16.07
-14.18%
18.73
+123.64%
8.37
+2.25%
8.19
Long Term Capital Lease Obligation
0.64
-75.14%
2.56
-17.78%
3.12
+20.49%
2.59
Long Term Provisions
1.40
+39.60%
1.00
+440.54%
0.18
+213.56%
0.06
Non Current Pension And Other Postretirement Benefit Plans
—
0.00
-100.00%
0.01
0.00
Non Current Deferred Liabilities
0.68
+38.70%
0.49
+5355.56%
0.01
0.00
Non Current Deferred Revenue
0.68
+44.28%
0.47
0.00
—
Non Current Deferred Taxes Liabilities
0.00
-100.00%
0.02
+111.11%
0.01
0.00
Other Non Current Liabilities
—
0.84
—
0.00
Stockholders Equity
49.13
-56.62%
113.25
+15.54%
98.02
-18.53%
120.32
Common Stock Equity
49.13
-56.62%
113.25
+15.54%
98.02
-18.53%
120.32
Capital Stock
6.50
+1.17%
6.43
+30.53%
4.93
+10.95%
4.44
Common Stock
6.50
+1.17%
6.43
+30.53%
4.93
+10.95%
4.44
Preferred Stock
—
—
—
0.00
Share Issued
43.03
+14.96%
37.43
+30.53%
28.67
+10.94%
25.85
Ordinary Shares Number
43.03
+14.96%
37.43
+30.53%
28.67
+10.94%
25.85
Additional Paid In Capital
335.13
+6.61%
314.35
+27.72%
246.13
+7.82%
228.28
Retained Earnings
-306.03
-40.55%
-217.74
-35.38%
-160.83
-36.05%
-118.21
Gains Losses Not Affecting Retained Earnings
1.12
+22.98%
0.91
+567.15%
0.14
-22.16%
0.18
Other Equity Adjustments
1.12
+22.98%
0.91
+567.15%
0.14
-22.16%
0.18
Total Equity Gross Minority Interest
49.13
-56.62%
113.25
+15.54%
98.02
-18.53%
120.32
Total Capitalization
65.20
-50.60%
131.98
+24.05%
106.39
-17.21%
128.51
Working Capital
12.26
-83.99%
76.55
+42.01%
53.91
-36.84%
85.35
Invested Capital
88.19
-33.31%
132.23
+23.86%
106.76
-17.18%
128.90
Total Debt
40.48
+78.67%
22.65
+78.31%
12.70
+6.91%
11.88
Net Debt
9.06
—
—
—
Capital Lease Obligations
1.42
-61.52%
3.68
-7.23%
3.97
+20.03%
3.31
Net Tangible Assets
-0.98
-101.56%
62.87
+22.29%
51.41
-36.01%
80.35
Tangible Book Value
-0.98
-101.56%
62.87
+22.29%
51.41
-36.01%
80.35
Derivative Product Liabilities
1.60
—
—
—
Financial Assets
0.09
-18.75%
0.11
—
—
Other Equity Interest
12.39
+33.28%
9.30
+21.39%
7.66
+35.71%
5.64
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-68.98
-40.13%
-49.23
-9.93%
-44.78
-55.72%
-28.76
Cash Flow From Continuing Operating Activities
-68.98
-40.13%
-49.23
-9.93%
-44.78
-55.72%
-28.76
Net Income From Continuing Operations
-89.08
-57.85%
-56.43
-26.37%
-44.66
-48.58%
-30.06
Depreciation Amortization Depletion
4.48
+64.97%
2.72
+15.17%
2.36
+22.15%
1.93
Depreciation
2.25
+28.65%
1.75
+25.32%
1.40
+24.93%
1.12
Amortization Cash Flow
2.23
+130.85%
0.97
+0.42%
0.96
+18.33%
0.81
Depreciation And Amortization
4.48
+64.97%
2.72
+15.17%
2.36
+22.15%
1.93
Amortization Of Intangibles
2.23
+130.85%
0.97
+0.42%
0.96
+18.33%
0.81
Other Non Cash Items
2.76
+391.33%
-0.95
+51.49%
-1.95
-1103.70%
-0.16
Stock Based Compensation
4.89
+23.14%
3.97
+51.97%
2.61
-3.22%
2.70
Provisionand Write Offof Assets
0.38
-53.86%
0.82
+278.24%
0.22
+483.78%
0.04
Asset Impairment Charge
1.68
0.00
0.00
—
Operating Gains Losses
1.53
+186.33%
-1.78
-292.22%
0.93
+132.07%
-2.88
Gain Loss On Investment Securities
-1.59
-493.55%
0.40
+259.29%
-0.25
-109.30%
2.72
Unrealized Gain Loss On Investment Securities
0.05
0.00
0.00
—
Net Foreign Currency Exchange Gain Loss
2.96
+235.67%
-2.18
-285.14%
1.18
+121.02%
-5.60
Gain Loss On Sale Of PPE
0.16
0.00
0.00
—
Change In Working Capital
5.37
+81.33%
2.96
+184.77%
-3.49
-4162.79%
0.09
Change In Receivables
-2.14
-184.95%
-0.75
+51.23%
-1.54
-22100.00%
0.01
Change In Inventory
0.06
+104.00%
-1.40
+42.42%
-2.43
-353.92%
-0.54
Change In Payables And Accrued Expense
7.46
+45.78%
5.11
+967.64%
0.48
-22.11%
0.61
Change In Payable
7.46
+45.78%
5.11
+967.64%
0.48
-22.11%
0.61
Investing Cash Flow
28.33
+273.55%
-16.32
-151.00%
32.01
+135.59%
-89.95
Cash Flow From Continuing Investing Activities
28.33
+273.55%
-16.32
-151.00%
32.01
+135.59%
-89.95
Net PPE Purchase And Sale
-0.80
+30.74%
-1.16
+53.68%
-2.50
-182.17%
-0.89
Purchase Of PPE
-0.81
+30.90%
-1.17
+53.40%
-2.50
-182.17%
-0.89
Sale Of PPE
0.00
-57.14%
0.01
0.00
0.00
Capital Expenditure
-3.77
+37.93%
-6.07
+44.61%
-10.96
+32.95%
-16.35
Capital Expenditure Reported
-2.96
+39.60%
-4.91
+42.01%
-8.46
+45.28%
-15.46
Net Investment Purchase And Sale
29.95
+339.20%
-12.52
-130.79%
40.66
+155.17%
-73.71
Purchase Of Investment
-42.05
+57.02%
-97.83
-22.26%
-80.02
+22.02%
-102.62
Sale Of Investment
72.00
-15.61%
85.31
-29.31%
120.68
+317.39%
28.91
Financing Cash Flow
38.11
-50.79%
77.44
+359.36%
16.86
+1814.95%
-0.98
Cash Flow From Continuing Financing Activities
38.11
-50.79%
77.44
+359.36%
16.86
+1814.95%
-0.98
Net Issuance Payments Of Debt
21.19
+150.01%
8.47
+785.68%
-1.24
-15.41%
-1.07
Issuance Of Debt
22.50
+125.00%
10.00
0.00
0.00
Repayment Of Debt
-1.31
+13.97%
-1.52
-23.38%
-1.24
-15.41%
-1.07
Long Term Debt Issuance
22.50
+125.00%
10.00
0.00
0.00
Long Term Debt Payments
-1.31
+13.97%
-1.52
-23.38%
-1.24
-15.41%
-1.07
Net Long Term Debt Issuance
21.19
+150.01%
8.47
+785.68%
-1.24
-15.41%
-1.07
Net Common Stock Issuance
20.86
-70.08%
69.72
+280.23%
18.34
+7090.98%
0.26
Cash Dividends Paid
0.00
0.00
0.00
0.00
Net Other Financing Charges
-3.25
-1140.84%
-0.26
-413.73%
-0.05
-37.84%
-0.04
Changes In Cash
-2.54
-121.37%
11.89
+190.59%
4.09
+103.42%
-119.69
Effect Of Exchange Rate Changes
-1.65
-339.10%
0.69
+286.45%
-0.37
-117.88%
2.06
Beginning Cash Position
34.19
+58.20%
21.61
+20.81%
17.89
-86.80%
135.51
End Cash Position
30.00
-12.24%
34.19
+58.20%
21.61
+20.81%
17.89
Free Cash Flow
-72.75
-31.56%
-55.30
+0.79%
-55.74
-23.58%
-45.10
Common Stock Issuance
20.86
-70.08%
69.72
+280.23%
18.34
+7090.98%
0.26
Interest Paid CFF
-0.69
-39.92%
-0.50
-158.33%
-0.19
-47.69%
-0.13
Interest Received CFI
2.15
-4.74%
2.26
-2.21%
2.31
+2000.00%
0.11
Interest Received CFO
—
0.00
0.00
-100.00%
0.00
Issuance Of Capital Stock
20.86
-70.08%
69.72
+280.23%
18.34
+7090.98%
0.26
Taxes Refund Paid
-1.04
-94.95%
-0.54
+32.19%
-0.79
-92.44%
-0.41
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category